Interleukin-6 (IL-6) mediates protection against glucose toxicity in human Müller cells via activation of VEGF-A signaling.
Coughlin, Brandon A
Interleukin-6 (IL-6) mediates protection against glucose toxicity in human Müller cells via activation of VEGF-A signaling. [electronic resource] - Biochemical and biophysical research communications 09 2019 - 227-232 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1090-2104
10.1016/j.bbrc.2019.07.044 doi
Cells, Cultured
Cytokine Receptor gp130--immunology
Diabetic Retinopathy--immunology
Glucose--immunology
Humans
Inflammation--immunology
Interleukin-6--immunology
Receptors, Interleukin-6--immunology
Retina--cytology
Signal Transduction
Vascular Endothelial Growth Factor A--immunology
Interleukin-6 (IL-6) mediates protection against glucose toxicity in human Müller cells via activation of VEGF-A signaling. [electronic resource] - Biochemical and biophysical research communications 09 2019 - 227-232 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1090-2104
10.1016/j.bbrc.2019.07.044 doi
Cells, Cultured
Cytokine Receptor gp130--immunology
Diabetic Retinopathy--immunology
Glucose--immunology
Humans
Inflammation--immunology
Interleukin-6--immunology
Receptors, Interleukin-6--immunology
Retina--cytology
Signal Transduction
Vascular Endothelial Growth Factor A--immunology